In vitro and in vivo preclinical venom inhibition assays identify metalloproteinase inhibiting drugs as potential future treatments for snakebite envenoming by Dispholidus typus

Snakebite envenoming affects more than 250,000 people annually in sub-Saharan Africa. Envenoming by Dispholidus typus (boomslang) results in venom-induced consumption coagulopathy (VICC), whereby highly abundant prothrombin-activating snake venom metalloproteinases (SVMPs) consume clotting factors a...

Descripción completa

Detalles Bibliográficos
Autores principales: Menzies, Stefanie K., Clare, Rachel H., Xie, Chunfang, Westhorpe, Adam, Hall, Steven R., Edge, Rebecca J., Alsolaiss, Jaffer, Crittenden, Edouard, Marriott, Amy E., Harrison, Robert A., Kool, Jeroen, Casewell, Nicholas R.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Toxins from venomous and poisonous animal
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935517/
https://www.ncbi.nlm.nih.gov/pubmed/35321116
http://dx.doi.org/10.1016/j.toxcx.2022.100118

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8935517/
https://www.ncbi.nlm.nih.gov/pubmed/35321116
http://dx.doi.org/10.1016/j.toxcx.2022.100118

Ejemplares similares